drugset / Trial / NCT05241470

Study of ST-100 as Treatment for Dry Eye Disease

NCT05241470 ↗

Phase 2 Completed 160 enrolled Stuart Therapeutics, Inc. ORA, Inc. · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The objective of this study is to compare the safety and efficacy of two different concentrations of ST-100 Ophthalmic Solution to placebo (vehicle) for the treatment of the signs and symptoms of dry eye.

Timeline

Start
2021-05-17
Primary completion
2021-10-11
Completion
2021-10-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator vezocolmitide Protein / enzyme biologic 20 ug/ml Topical
Comparator vezocolmitide Protein / enzyme biologic 50 ug/ml Topical

Indications